Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Pollack, MD
Philadelphia Institute of Dermatology
Principal Investigator - Angela Moore, MD
Arlington Center for Dermatology
Principal Investigator - Dow Stough, MD
Burke Pharmaceutical Research
Principal Investigator - Fran Cook-Bolden, MD
Skin Specialty Group
Principal Investigator - Girish Munavalli, MD
Dermatology, Laser & Vein Specialists of the Carolinas
Principal Investigator - Harry Sharta, MD
Madison Skin & Research
Principal Investigator - Kappa Meadows, MD
The Education & Research Foundation
Principal Investigator - Kimberly Grande, MD
The Skin Wellness Center
Principal Investigator - Mark Ling, MD
Meda Phase, Inc.
Principal Investigator - Martin Steinhoff, MD
University of California at San Francisco
Principal Investigator - Michael Graeber, MD
Galderma R&D, Inc
Study Director - Michael Heffernan, MD
Central Dermatology PC
Principal Investigator - Patricia Westmoreland, MD
Palmetto Clinical Trial Services, LLC
Principal Investigator - Phoebe Rich, MD
Oregon Dermatology & Research Center
Principal Investigator - Robert Matheson, MD
Oregon Medical Research
Principal Investigator - Stephen Schleicher, MD
DermDox
Principal Investigator - Steven Kempers, MD
Minnesota Clinical Study Center
Principal Investigator - William Abramovits, MD
Dermatology Treatment & Research Center
Principal Investigator - William Werschler, MD
Premier Clinical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Burke Pharmaceutical Research
Hot Springs, Arkansas, United States
- University of California at San Francisco
San Francisco, California, United States
- Meda Phase, Inc
Newnan, Georgia, United States
- Dermatology Specialists Pc
Louisville, Kentucky, United States
- Minnesota Clinical Study Center
Fridley, Minnesota, United States
- Central Dermatology, Pc
St Louis, Missouri, United States
- Skin Specialty Group
New York, New York, United States
- Dermatology Laser & Vein Specialists
Charlotte, North Carolina, United States
- Dermatology Consulting Services
High Point, North Carolina, United States
- Oregon Dermatology & Research Center
Portland, Oregon, United States
- Oregon Medical Research
Portland, Oregon, United States
- Philadelphia Institute of Dermatology
Fort Washington, Pennsylvania, United States
- Dermdox
Hazleton, Pennsylvania, United States
- Palmetto Clinical Trial Services, Llc
Greenville, South Carolina, United States
- the Skin Wellness Center
Knoxville, Tennessee, United States
- Arlington Center for Dermatology
Arlington, Texas, United States
- Dermatology Treatment & Research Center
Dallas, Texas, United States
- the Education & Research Foundation
Lynchburg, Virginia, United States
- Premier Clinical Research
Spokane, Washington, United States
- Madison Skin & Research
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2010
- Primary completion
- 31 Dec 2010
- Completion
- 31 Jan 2011
- Last update posted
- 26 Feb 2021
- Registered enrollment
- 269
- Registry id
- NCT01174030
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.